Status:
UNKNOWN
Comparison of Drugs on Headache Treatment After ECT Treatment
Lead Sponsor:
Mustafa Kemal University
Conditions:
Mental Disorders
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
Electroconvulsive treatment (ECT) is still actual for treatment of psychiatric symptoms. Headache is a very common symptom after this application. The investigators compare the effect of two different...
Detailed Description
Electroconvulsive treatment (ECT) is used as an alternative application instead of drug therapy for psychiatric symptoms. ECT application is repeated 8-12 times according to the treatment of the patie...
Eligibility Criteria
Inclusion
- All patients who were admitted for ECT and gave informed written consent were included in the study.
Exclusion
- Exclusion criteria included patients who gave a history of allergy to acetaminophen, lacked capacity to give informed consent and developed complications such as delirium following ECT.
Key Trial Info
Start Date :
November 20 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2019
Estimated Enrollment :
225 Patients enrolled
Trial Details
Trial ID
NCT03830398
Start Date
November 20 2018
End Date
June 1 2019
Last Update
February 5 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mustafa Kemal University Medicine Faculty Anesthesiology Department
Hatay, Turkey (Türkiye), 31000